Magnesium is an essential element and has a fundamental role in carbohydrate metabolism in general and in the insulin action in particular. Magnesium is involved in multiple levels in insulin secretion, binding and activity. Cellular magnesium deficiency can alter the activity of the membrane bound Na+K+ ATPase, which is involved in the maintenance of gradients of sodium and potassium and in glucose transport (1).
with hypomagnesaemia. Decrements in the enzymatic activities of several metabolic pathways are seen in DM patients as a result of the relative magnesium deficiency (7) .
Various evidences suggesting a relationship of Mg deficiency and type 2 diabetes mellitus (T2DM), T2DM is a main global public health problem in the world and is rising in aging populations (4) . In the study conducted by Dasgupta et al on 150 T2DM patients, low Mg level was documented in 11.33% of patients. They interpreted that hypomagnesaemia in diabetes mellitus was correlated with poorer diabetic control, nephropathy, retinopathy and foot ulcers (8) .
The mechanism behind the role of magnesium deficiency in the development of diabetic microvascular complications has not been well investigated. However, significant clues can be extrapolated from previous studies. Serum magnesium levels are associated with insulin resistance and β cell function in patients with diabetes.
Furthermore, magnesium deficiency is associated with decreased β cell function and increased insulin resistance, leading to elevated plasma glucose levels (9).
Aim of work:
To study serum magnesium level as a marker for development of diabetic nephropathy.
Subjects and methods:
This study included 105 adult patients from outpatient clinic of Internal medicine department in Fayoum University Hospital from December, 2016 to May, 2017.
All patients were diagnosed as having type 2 diabetes mellitus (T2DM).The diagnosis of T2DM was made on the usual criteria(fasting blood sugar and 2 hours post prandial glucose measurement in blood)earlier during their follow up outpatient.
Informed consent was obtained from the patients.
All patients were subjected to:
Full clinical examination. The height and weight were measured and obesity was defined as body mass index (BMI) of ≥30 kg/m2 , where BMI was calculated by dividing the weight in kilograms on height in meters squared.
3)Laboratory investigations:
 Serum cratinine.
 Albumin / creatinine ratio.
 Serum magnesium.
Serum sample preparation:
Laboratory data including serum cratinine, HbA1c, albumin creatinine ratio and serum magnesium levels were measured using standard methodology in the clinical chemistry laboratory of Fayoum university hospital. Blood for determination of Mg was sampled into plain evacuated glass tubes with glycerine caps, while Vacutainer tubes were used for the other analytes. The samples were allowed to coagulate for at least 30 min at room temperature and were then centrifuged for 3 min at 2,000 rpm and stored in plastic vials at -25°C until analysis.
Reference values of measured investigation:
Microalbuminuria, which is defined as 30-300 mg/g creatinine, is a sign of progression towards nephropathy in patients with diabetes (10).Albuminuria is a sensitive marker of renal dysfunction, and the American Diabetes Association has recommended annual testing for albuminuria in 12-or 24-hr urine samples to predict the risk of cardiovascular disease and renal dysfunction in cases of diabetes mellitus (11) . Samples with ACR values of 30-300 or >300 mg/g were considered "positive,"
while those with values of <30 mg/g were considered "negative (12) . This work showed that lower magnesium level was detected in patients with diabetic nephropathy (as marked by albuminuria >30 mg/dl) more than diabetic patients without nephropathy (p-value:0.006). In a study conducted by Jayaraman et al., the level of magnesium decreases with increasing glucose levels, much more before the onset of diabetic micro and macro vascular complications. This can be used as a marker to assess the risk of complication even at the first encounter with diabetic patients (20) .The work of Yossef et al conducted on 90 patients, serum Mg was significantly lower in diabetic patients than in control (P=0.007). Mg was lower in patients with complications than in patients without (21) .,in addition to that the study conducted by Corsenello et al Henle, where; 55% of the filtered Mg is reabsorbed (27) .Therefore, in patients with type 2 diabetes, insulin resistance or deficiency can promote Mg loss at the thick ascending limb , which might compensate for the reduced glomerular filtration ((28).
In present study, there is no significant correlation was found between body mass index and albuminuria,also there was no correlation between waist hip ratio and albuminuria.this may be explained by the fact that Body mass index does not account for the wide variations in body fat distribution as a high BMI may be due to increased muscle bulk (29) .while an increased waist hip ratio may be due an in increase in the subcutaneous fat and not the visceral fat and visceral is the responsible for diabetic complications (30) .
Recommendations
Routine surveillance for hypomagnesemia should be done and the condition to be treated whenever possible.When hypomagnesemia is found, patients should be further investigated for complications of diabetes.
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